Please login to the form below

Not currently logged in
Email:
Password:

PCSK9 inhibitors

This page shows the latest PCSK9 inhibitors news and features for those working in and with pharma, biotech and healthcare.

Esperion gets FDA thumbs up for cholesterol drug Nexletol

Esperion gets FDA thumbs up for cholesterol drug Nexletol

It will launch into a cholesterol market that was static for years and remains dominated by statins, but has seen a couple of new entrants – two injectable PCSK9 inhibitors from Amgen ... and Sanofi/Regeneron – and could see a launch later this year

Latest news

More from news
Approximately 1 fully matching, plus 40 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...

Infographics